Valeant Pharmaceuticals to Present at Deutsche Bank Securities, Inc. 37th Annual Health Care Conference
MONTREAL, April 27, 2012 /PRNewswire/ -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) today announced members of its senior management team will make a presentation at the Deutsche Bank Securities, Inc. 37th Annual Health Care Conference on Monday, May 7, 2012 at 2:50 p.m. ET. The conference will be held at the InterContinental Hotel in Boston.
A live webcast and audio archive of the presentation will be available on the company's Web site at www.valeant.com. Click on Investor Relations, and then the link to Events and Presentations. Participants should allow approximately five to ten minutes prior to the presentation's start time to visit the site and download any streaming media software needed to listen to the Internet webcast. The webcast can also be accessed through the following URL: http://www.media-server.com/m/p/4c46bofr
Valeant Pharmaceuticals International, Inc. (NYSE: VRX/TSX) is a multinational specialty pharmaceutical company that develops, manufactures and markets a broad range of pharmaceutical products primarily in the areas of neurology, dermatology and branded generics. More information about Valeant can be found at www.valeant.com.
SOURCE Valeant Pharmaceuticals International, Inc.
More by this Source
Actavis and Valeant Announce FDA Approval for Metronidazole 1.3%
Mar 25, 2014, 17:00 ET
Valeant Pharmaceuticals Reports Fourth Quarter And Full Year 2013 Financial Results
Feb 27, 2014, 06:00 ET
Browse our custom packages or build your own to meet your unique communications needs.
Learn about PR Newswire services
Request more information about PR Newswire products and services or call us at (888) 776-0942.